Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab
NCT03115255
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Infant, Premature, Diseases
Interventions
DRUG:
intravitreal ranibizumab
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine